A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas

NCT00878800 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Dose Escalation: Solid Tumors
MTD: Soft Tissue Sarcomas

Interventions

DRUG: PXD101
DRUG: Doxorubicin

Sponsor

Valerio Therapeutics

Collaborators

[object Object]